You are here

Hematology/Oncology Associates of Central NY receives CEO Cancer Gold Standard™ Accreditation

October 17, 2011
Cary, NC

Hematology/Oncology Associates of Central NY (HOA), has received CEO Cancer Gold Standard™ accreditation, recognizing the hospital’s commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment for their own employees and their covered family members.

Christopher A. Viehbacher chairs the CEO Roundtable on Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard™, in collaboration with the National Cancer Institute, many of its designated cancer centers, and leading health non-profit organizations and professionals. Today, more than two and a half million employees and family members are benefiting from the vision and leadership of employers like HOA who have chosen to become Gold Standard accredited.

 “CEO Cancer Gold Standard accreditation is further testament that HOA’s efforts to improve health begin with improving the health of their own employees,” said Christopher A. Viehbacher, CEO of Sanofi. 

The CEO Cancer Gold Standard™ calls for companies to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. To earn Gold Standard accreditation, a company must establish programs to reduce cancer risk by discouraging tobacco use; encouraging physical activity; promoting healthy nutrition; detecting cancer at its earliest stages; and providing access to quality care, including participation in clinical trials.